Literature DB >> 24076587

Mapping the p53 transcriptome universe using p53 natural polymorphs.

B Wang1, D Niu1, T H Lam2, Z Xiao1, E C Ren2.   

Abstract

The tumor suppressor p53 has defined roles in varied cellular processes including apoptosis and DNA repair. While conventional genomic approaches have suggested a large number of p53 targets, there is a need for a systematic approach to validate these putative genes. We developed a method to identify and validate p53's transcriptional behavior by utilizing 16 non-synonymous p53 single-nucleotide polymorphism (SNP) variants. Five SNPs located within the DNA-binding domain of p53 were found to be functionally null, whereas the other 11 SNPs were p53WT-like in behavior. By integrating p53 ChIP-seq analysis with transcriptome data from the p53 SNP variants, 592 genes were identified as novel p53 targets. Many of these genes mapped to previously less well-characterized aspects of p53 function, such as cell signalling, metabolism, central nervous system, and immune system. These data provide pivotal insights into the involvement of p53 in diverse pathways of normal physiological processes and open new avenues for investigation of p53 function.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24076587      PMCID: PMC3950315          DOI: 10.1038/cdd.2013.132

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  40 in total

1.  p53-dependent pathways of apoptosis.

Authors:  S Benchimol
Journal:  Cell Death Differ       Date:  2001-11       Impact factor: 15.828

2.  Importance of replication in microarray gene expression studies: statistical methods and evidence from repetitive cDNA hybridizations.

Authors:  M L Lee; F C Kuo; G A Whitmore; J Sklar
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

3.  Definition of a consensus binding site for p53.

Authors:  W S el-Deiry; S E Kern; J A Pietenpol; K W Kinzler; B Vogelstein
Journal:  Nat Genet       Date:  1992-04       Impact factor: 38.330

4.  Analyses of p53 target genes in the human genome by bioinformatic and microarray approaches.

Authors:  L Wang; Q Wu; P Qiu; A Mirza; M McGuirk; P Kirschmeier; J R Greene; Y Wang; C B Pickett; S Liu
Journal:  J Biol Chem       Date:  2001-09-24       Impact factor: 5.157

5.  Modulation of gene expression by tumor-derived p53 mutants.

Authors:  Mariano J Scian; Katherine E R Stagliano; Michelle A Ellis; Sajida Hassan; Melissa Bowman; Michael F Miles; Swati Palit Deb; Sumitra Deb
Journal:  Cancer Res       Date:  2004-10-15       Impact factor: 12.701

6.  p53RFP, a p53-inducible RING-finger protein, regulates the stability of p21WAF1.

Authors:  Ching-Ching Ng; Hirofumi Arakawa; Seisuke Fukuda; Hisato Kondoh; Yusuke Nakamura
Journal:  Oncogene       Date:  2003-07-10       Impact factor: 9.867

7.  Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence.

Authors:  Akinori Takaoka; Sumio Hayakawa; Hideyuki Yanai; Dagmar Stoiber; Hideo Negishi; Hideaki Kikuchi; Shigeru Sasaki; Kohzoh Imai; Tsukasa Shibue; Kenya Honda; Tadatsugu Taniguchi
Journal:  Nature       Date:  2003-07-31       Impact factor: 49.962

8.  In vivo activation of the p53 pathway by small-molecule antagonists of MDM2.

Authors:  Lyubomir T Vassilev; Binh T Vu; Bradford Graves; Daisy Carvajal; Frank Podlaski; Zoran Filipovic; Norman Kong; Ursula Kammlott; Christine Lukacs; Christian Klein; Nader Fotouhi; Emily A Liu
Journal:  Science       Date:  2004-01-02       Impact factor: 47.728

9.  STAT4 serine phosphorylation is critical for IL-12-induced IFN-gamma production but not for cell proliferation.

Authors:  Akio Morinobu; Massimo Gadina; Warren Strober; Roberta Visconti; Albert Fornace; Cristina Montagna; Gerald M Feldman; Ryuta Nishikomori; John J O'Shea
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-04       Impact factor: 11.205

10.  Insights into p53 transcriptional function via genome-wide chromatin occupancy and gene expression analysis.

Authors:  F Nikulenkov; C Spinnler; H Li; C Tonelli; Y Shi; M Turunen; T Kivioja; I Ignatiev; A Kel; J Taipale; G Selivanova
Journal:  Cell Death Differ       Date:  2012-07-13       Impact factor: 15.828

View more
  31 in total

1.  The effect of non-coding DNA variations on P53 and cMYC competitive inhibition at cis-overlapping motifs.

Authors:  Katherine Kin; Xi Chen; Manuel Gonzalez-Garay; Walid D Fakhouri
Journal:  Hum Mol Genet       Date:  2016-02-07       Impact factor: 6.150

2.  p53-dependent non-coding RNA networks in chronic lymphocytic leukemia.

Authors:  C J Blume; A Hotz-Wagenblatt; J Hüllein; L Sellner; A Jethwa; T Stolz; M Slabicki; K Lee; A Sharathchandra; A Benner; S Dietrich; C C Oakes; P Dreger; D te Raa; A P Kater; A Jauch; O Merkel; M Oren; T Hielscher; T Zenz
Journal:  Leukemia       Date:  2015-05-14       Impact factor: 11.528

3.  Expanding the reach of the p53 tumor suppressor network.

Authors:  G P Zambetti
Journal:  Cell Death Differ       Date:  2014-04       Impact factor: 15.828

4.  A comprehensive and high-resolution genome-wide response of p53 to stress.

Authors:  Gue Su Chang; Xiangyun Amy Chen; Bongsoo Park; Ho Sung Rhee; Pingxin Li; Kang Hoo Han; Tejaswini Mishra; Ka Yim Chan-Salis; Yunfei Li; Ross C Hardison; Yanming Wang; B Franklin Pugh
Journal:  Cell Rep       Date:  2014-07-17       Impact factor: 9.423

5.  Variable population prevalence estimates of germline TP53 variants: A gnomAD-based analysis.

Authors:  Kelvin C de Andrade; Megan N Frone; Talia Wegman-Ostrosky; Payal P Khincha; Jung Kim; Amina Amadou; Karina M Santiago; Fernanda P Fortes; Nathanaël Lemonnier; Lisa Mirabello; Douglas R Stewart; Pierre Hainaut; Luiz P Kowalski; Sharon A Savage; Maria I Achatz
Journal:  Hum Mutat       Date:  2018-11-19       Impact factor: 4.878

Review 6.  The p53 status in rheumatoid arthritis with focus on fibroblast-like synoviocytes.

Authors:  Mahdi Taghadosi; Mehrnoosh Adib; Ahmadreza Jamshidi; Mahdi Mahmoudi; Elham Farhadi
Journal:  Immunol Res       Date:  2021-05-13       Impact factor: 2.829

7.  Cooperative interactions between p53 and NFκB enhance cell plasticity.

Authors:  Alessandra Bisio; Judit Zámborszky; Sara Zaccara; Mattia Lion; Toma Tebaldi; Vasundhara Sharma; Ivan Raimondi; Federica Alessandrini; Yari Ciribilli; Alberto Inga
Journal:  Oncotarget       Date:  2014-12-15

8.  Integrative genomic analysis reveals widespread enhancer regulation by p53 in response to DNA damage.

Authors:  Scott T Younger; Daniela Kenzelmann-Broz; Heiyoun Jung; Laura D Attardi; John L Rinn
Journal:  Nucleic Acids Res       Date:  2015-04-16       Impact factor: 16.971

9.  Peritoneal expression of Matrilysin helps identify early post-operative recurrence of colorectal cancer.

Authors:  Giuseppe S Sica; Cristina Fiorani; Carmine Stolfi; Giovanni Monteleone; Eleonora Candi; Ivano Amelio; Valeria Catani; Simone Sibio; Andrea Divizia; Giorgia Tema; Edoardo Iaculli; Achille L Gaspari
Journal:  Oncotarget       Date:  2015-05-30

10.  Whole-genome cartography of p53 response elements ranked on transactivation potential.

Authors:  Toma Tebaldi; Sara Zaccara; Federica Alessandrini; Alessandra Bisio; Yari Ciribilli; Alberto Inga
Journal:  BMC Genomics       Date:  2015-06-17       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.